Target intelligence / Profile preview

RNA, U1 small nuclear 89, pseudogene (RNU1-89P)

Target
RNU1-89P
Molecular classification
Other (non-coding RNA, pseudogene)
01

Overview

RNU1-89P is a pseudogene of the RNA, U1 small nuclear family, located on chromosome 4q28[2][3][4]. Unlike active protein-coding or functional non-coding RNA genes, RNU1-89P is classified as a pseudogene and is not believed to produce a functional transcript or participate in cellular processes such as splicing, as its canonical counterpart (e.g., RNU1-1) does[4]. There is insufficient evidence for RNU1-89P having a direct biological function, clinical disease role, or utility as a therapeutic target. Key context: RNU1-89P is not listed as an enzyme, receptor, transporter, or other commonly targeted biomolecule in drug development. There are no reports of drug interactions, clinical biomarker utility, or safety concerns related to targeting it. Its close relatives (such as RNU1-1/U1 snRNA) play critical roles in pre-mRNA splicing and transcript stability, but pseudogenes like RNU1-89P are generally considered nonfunctional genomic elements[4]. This entry should not be considered a therapeutic target, and requesting structured drug-target data for it will yield null or not applicable results. Notes on potential error: The designation "pseudogene" means it is not considered a functional molecular target, which makes it incorrect as a therapeutic or diagnostic target request[4]. This entry is correct as a genomic locus, but it is incorrect if interpreted as a functional drug target or receptor.

Other names
RNU1-89P

Beyond the preview

Go deeper on RNA, U1 small nuclear 89, pseudogene (RNU1-89P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 89, pseudogene (RNU1-89P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call